CapRock Research Initiates Analyst Coverage on Livedeal with $7.15 Price Target Issued By Small Cap Traders and 4 Brief Reports
February 19 2015 - 12:30PM
InvestorsHub NewsWire
NEW YORK, NY -- February 19, 2015 -- InvestorsHub NewsWire
-- SmallCapTraders.com initiates coverage of LiveDeal, Inc.
(NASDAQ: LIVE)
This week’s feature profile has a great chart setup with uptrend
forming and a recent pull back to breathe a little here for the
next run up.
Couple that with this announcement last week- “Largest Quarterly
Sales and Biggest Increase in Revenue in Company History”
Full press release: http://www.prnewswire.com/news-releases/livedeal-inc-announces-largest-quarterly-sales-and-biggest-increase-in-revenue-in-company-history-291645661.html
LiveDeal, Inc. (NASDAQ: LIVE) “Simple yet genius marketing
company”
Highlights
• Company announces record revenues and revenue increase for the
December 31, 2014 quarter.
• Company has created over 10,000 deals for over 8,000 clients in
over 50 cities nationwide.
• Company added 4,457 new restaurant deals during the fourth
quarter of fiscal 2014, up over 1,100 deals sequentially.
Great potential here with LIVE for a short squeeze in the near
term.
LIVE Full Profile:
http://smallcapir.com/?p=2666
4 Brief Reports:
InterDigital, Inc. (NASDAQ: IDCC) develops technologies that are at
the core of mobile devices, networks, and services worldwide. We
solve many of the industry's most critical and complex technical
challenges, inventing solutions for more efficient broadband
networks and richer multimedia experience years ahead of market
deployment. InterDigital has licenses and strategic relationships
with many of the world's leading wireless companies.
The company's stock will be added to the NASDAQ US Buyback
Achievers Index and a company executive has been named to a
prestigious Board. Read about these developments in this report:
http://bit.ly/-IDCC-AnalystBrief
FXCM, Inc. (NYSE: FXCM) is a global online provider of foreign
exchange (forex) trading and related services to retail and
institutional customers world-wide. At the heart of FXCM's client
offering is No Dealing Desk forex trading. Clients have the
advantage of mobile trading, one-click order execution and trading
from real-time charts. FXCM's U.K. subsidiary, Forex Capital
Markets Limited, also offers CFD products with no re-quote trading
and allows clients to trade oil, gold, silver and stock indices
along with forex on one platform.
After the disruption caused by the drastic movement of the Swiss
Franc in January, the company has updated some of its recent
operating metrics. Read about it here in this report: http://bit.ly/-FXCM-AnalystBrief
Amarin Corp, PLC. (NASDAQ: AMRN) is a biopharmaceutical company
focused on the commercialization and development of therapeutics to
improve cardiovascular health. Amarin's product development program
leverages its extensive experience in lipid science and the
potential therapeutic benefits of polyunsaturated fatty acids.
Vascepa® (icosapent ethyl), Amarin's first FDA-approved product, is
an ultra-pure, EPA-only omega-3 fatty acid product available by
prescription.
Rick Harrison, the star of “Pawn Stars” takes Vascepa®. Read his
story in the report you can access at the following link: http://bit.ly/-AMRN-AnalystBrief
iBio, Inc. (NYSE-MKT: IBIO) is developing a proprietary product,
IBIO-CFB03, for the treatment of idiopathic pulmonary fibrosis,
systemic sclerosis, and other fibrotic diseases using its
iBioLaunch(TM) gene expression platform. The company also offers
proprietary products and product licenses to others, based on its
proprietary iBioLaunch(TM) gene expression and iBioModulator(TM)
thermostable immunomodulator protein platforms.
Full report here: http://bit.ly/-IBIO-AnalystBrief
About Small Cap Traders
We make the connection between sophisticated investors and high
quality small cap companies. An issuer of reports written by
chartered financial analysts (CFA’s) who provide a straightforward
assessment of the profiled company and have pledged to remain free
of influence when writing research reports. They include stocks
traded in the NYSE, NASDAQ, and OTCBB exchanges.
For more information and services provided beyond this release
please use contact information provided below.
Forward-Looking Disclaimer
This report may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, and is subject to the Safe Harbor created by those
sections. This material contains statements about expected future
events and/or financial results that are forward-looking in nature
and subject to risks and uncertainties. Such forward- looking
statements by definition involve risks, uncertainties and other
factors, which may cause the actual results, performance or
achievements of mentioned company to be materially different from
the statements made herein.
Compliance Procedure
Content is researched, written and reviewed on a best-effort basis
by a 3rd party research analyst. However, we are only human and are
prone to make mistakes. If you notice any errors or omissions,
please notify us below. We do not engage in high frequency
trading.
A full disclaimer can be found by viewing the analyst report.
If you wish to have a company covered in more detail by our team,
or wish to learn more about our services, please contact us at
editor@smallcaptraders.com. For any urgent concerns or inquiries
please contact us at editor@smallcaptraders.com.
Source: Small Cap Traders
Contact: editor@smallcaptraders.com
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024